SCLC, LIMITED STAGE
Clinical trials for SCLC, LIMITED STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, LIMITED STAGE trials appear
Sign up with your email to follow new studies for SCLC, LIMITED STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients: drug may keep cancer at bay after standard treatment
Disease control Recruiting nowThis study tests whether a drug called adebrelimab can help keep limited-stage small cell lung cancer from coming back after initial chemotherapy and radiation. About 200 adults aged 18-75 with untreated, limited-stage disease will be randomly assigned to receive either standard …
Matched conditions: SCLC, LIMITED STAGE
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New study checks if immunotherapy drug durvalumab helps lung cancer patients after standard treatment
Disease control Recruiting nowThis study looks at the safety and effectiveness of the immunotherapy drug durvalumab in 25 people with limited-stage small cell lung cancer who have already had chemotherapy and radiation. The drug is given as a follow-up treatment to try to keep the cancer from coming back. Res…
Matched conditions: SCLC, LIMITED STAGE
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New PET scan probe could sharpen lung cancer detection
Diagnosis Recruiting nowThis study is testing a new radioactive probe called PFD3, used with a PET/CT scan, to see if it can better find and assess small cell lung cancer (SCLC) by targeting a protein called DLL3 found on cancer cells. About 30 adults with SCLC will receive both a standard FDG scan and …
Matched conditions: SCLC, LIMITED STAGE
Phase: PHASE1, PHASE2 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC